Replies to post #145211 on Biotech Values

[jbog]

"""Along with its U.S. plans, Ranbaxy is working to expand generic sales in emerging markets. Those are heavily populated countries with a growing middle class and rising government spending on health care, from India and China to Brazil and Russia."""

I'm not sure I'd use the above statement to claim that Ranbaxy has "big plans" for emerging markets?